Blauvelt, A. .; Thaci, D.; Papp, K.; Ho, V. .; Ghoreschi, K.; Kim, B. S.; Miller, M. .; Shen, Y.-K. .; You, Y.; Yu, J.; Yang, Y.-W.; Crowley, J.; Foley, P. Guselkumab (GUS) in Psoriasis Patients With a History of Malignancy: 5-Year Safety From VOYAGE (VOY)1&2. J of Skin 2022, 6, s2.